MOLECULAR PARTNERS AG Finance Costs
MOLECULAR PARTNERS AG (MOLN) reported Finance Costs of CHF 5.05 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-03-12
- MOLECULAR PARTNERS AG finance costs for the quarter ending 2025-06-30 was 3.50M CHF, a 19350.00% increase year-over-year.
- MOLECULAR PARTNERS AG finance costs for the quarter ending 2024-06-30 was 18.00K CHF, a 98.49% decline year-over-year.
- MOLECULAR PARTNERS AG finance costs for the quarter ending 2023-06-30 was 1.19M CHF, a 394.61% increase year-over-year.
- MOLECULAR PARTNERS AG finance costs for the quarter ending 2022-06-30 was 241.00K CHF.
| Period end | Finance Costs 3 month | Finance Costs 6 month | Finance Costs 12 month |
|---|---|---|---|
| 2025-12-31 | 5.05M CHF 20-F · filed 2026-03-12 | ||
| 2025-06-30 | 3.50M CHF 6-K · filed 2025-08-25 | 4.63M CHF 6-K · filed 2025-08-25 | |
| 2024-12-31 | 38.00K CHF 20-F · filed 2026-03-12 | ||
| 2024-06-30 | 18.00K CHF 6-K · filed 2025-08-25 | 20.00K CHF 6-K · filed 2025-08-25 | |
| 2023-12-31 | 5.16M CHF 20-F · filed 2026-03-12 | ||
| 2023-06-30 | 1.19M CHF 6-K · filed 2024-08-26 | 1.75M CHF 6-K · filed 2024-08-26 | |
| 2022-12-31 | 619.00K CHF 20-F · filed 2025-03-06 | ||
| 2022-06-30 | 241.00K CHF 6-K · filed 2023-08-24 | 490.00K CHF 6-K · filed 2023-08-24 | |
| 2021-12-31 | 556.00K CHF 20-F · filed 2024-03-14 | ||
| 2021-06-30 | 319.00K CHF 6-K/A · filed 2022-08-31 | ||
| 2020-12-31 | 4.82M CHF 20-F · filed 2023-03-09 | ||
| 2019-12-31 | 1.21M CHF 20-F · filed 2022-03-15 |